Skip to main content
Logo
European Innovation Council

TILT Biotherapeutics OY

The company develops cancer immunotherapies using engineered oncolytic adenoviruses to enhance T-cell responses.

  • public sector
TILT Biotherapeutics Logo

Overview

Description

The company develops cancer immunotherapies using engineered oncolytic adenoviruses to enhance T-cell responses.

Website

https://tiltbio.com/

Country
  • Finland
Sector
  • Health Biotechnology

Engage with TILT Biotherapeutics OY*

*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.